NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Lab-grown meat: you may find it icky, but it could drive forward medical research 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement 
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits 
Eli Lilly’s Weight-Loss Pill Nears Fast-Track FDA Approval as Profits Surge on Global Demand 
Kennedy Sets September Deadline to Uncover Autism Causes Amid Controversy 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Innovent’s Xinermei Intensifies Weight-Loss Drug Battle in China 
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio 
SpaceX Starship Explodes in Texas During Test, Citing Nitrogen Tank Failure 
The COVID-19 pandemic has affected many people all over the world, forcing people to spend most of the year indoors until a vaccine or cure is developed. As countries experience another wave of coronavirus cases, scientists were able to discover the reason behind one particular symptom of the disease.
One of the discovered symptoms of COVID-19 is the loss of smell and taste, also known as ansomnia. While the common cold and the flu are common symptoms, many are revealed to have ansomnia as their only symptom of the disease. A new study revealed why people experience this symptom and it has something to do with a particular protein found on the surface of certain cells. The cells to be specific are those found in the throat, nose, heart, lungs, and gut.
The protein is called ACE-2 or “angiotensin-converting enzyme II” which has a certain shape that allows it to take the hormone angiotensin and turn it into angiotensin II, which is used for certain functions like regulating blood pressure. ACE-2’s shape with angiotensin is also similar to its shape when it binds to the outer proteins of the coronavirus.
A group of scientists from Johns Hopkins found very high levels of that same protein found in the olfactory epithelium - the tissue in the nose that is used to detect smells. To be specific, they found 200 to 700 times higher than other parts of the nose.
According to the study’s author, Professor Andrew P. Lane, “The olfactory-supporting cells are necessary to protect and maintain the delicate neurons in the nose that detect odors and signal that information to the brain. Generally speaking, when cells are reinfected with the virus, they undergo a process called pyroptosis - essentially hitting the self-destruct button to foil the virus. So, most likely, olfactory-supporting cells destroy themselves, leading in turn to the death of sensory neurons and loss of the sense of smell.”
Another scientist, Dr. David Strain from the University of Exeter, found that some COVID-19 patients are still experiencing some symptoms long after the initial infection. Dr. Strain explained that this happens more in women than in men, in what he described as “long Covid” where the symptoms last for months. Even with the symptoms, they have yet to figure out why this condition occurs in patients, even in those who have recovered.
